Inhibiting enhancer of zeste homolog 2 promotes cellular senescence in gastric cancer cells SGC-7901 by activation of p21 and p16

DNA and Cell Biology

Volumn 33, Issue 6, 2014, Pages 337-344

  Bai, Jie ^a   Chen, Junhua ^a   Ma, Muyuan ^a   Cai, Ming ^a   Xu, Fei ^a   Wang, Guobin ^a   Tao, Kaixiong ^a   Shuai, Xiaoming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; LENTIVIRUS VECTOR; PROTEIN P16; PROTEIN P21; PROTEIN P53; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR EZH2;

ARTICLE; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CELLULAR SENESCENCE; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CONTROLLED STUDY; EPIGENETICS; GASTRIC CANCER CELL LINE; GENE ACTIVATION; GENE INACTIVATION; GENE P16; GENE P21; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SENESCENCE; TUMOR SUPPRESSOR GENE;

CELL AGING; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOXORUBICIN; HUMANS; NEOPLASM PROTEINS; POLYCOMB REPRESSIVE COMPLEX 2; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84901699683     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2014.2340     Document Type: Article

References (30)

1. Ajani, J.A. (2008). Gastroesophageal cancers: Progress and problems. J Natl Compr Canc Netw 6, 813-814
2. Balasubramanian, S., Adhikary, G., and Eckert, R.L. (2010). The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin- 3-gallate-dependent suppression of skin cancer cell survival. Carcinogenesis 31, 496-503
3. Balasubramanian, S., Lee, K., Adhikary, G., Gopalakrishnan, R., Rorke, E.A., and Eckert, R.L. (2008). The Bmi-1 polycomb group gene in skin cancer: Regulation of function by (-)- epigallocatechin-3-gallate. Nutr Rev 66 Suppl 1, S65-S68
4. Ben-Porath, I., and Weinberg, R.A. (2005). The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 37, 961-976. (Pubitemid 40311739)
5. Brown, J.P., Wei, W., and Sedivy, J.M. (1997). Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277, 831-834
6. Cakouros, D., Isenmann, S., Cooper, L., Zannettino, A., Anderson, P., Glackin, C., and Gronthos, S. (2012). Twist-1 induces Ezh2 recruitment regulating histone methylation along the Ink4A/Arf locus in mesenchymal stem cells. Mol Cell Biol 32, 1433-1441
7. Campisi, J., and d'Adda di Fagagna, F. (2007). Cellular senescence: When bad things happen to good cells. Nat Rev Mol Cell Biol 8, 729-740
8. Cheng, L.L., Itahana, Y., Lei, Z.D., Chia, N.Y., Wu, Y., Yu, Y., Zhang, S.L., Thike, A.A., Pandey, A., Rozen, S., Voorhoeve, P.M., Yu, Q., Tan, P.H., Bay, B.H., Itahana, K., and Tan, P. (2012). TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep). Clin Cancer Res 18, 4201-4212
9. Choi, J.H., Song, Y.S., Yoon, J.S., Song, K.W., and Lee, Y.Y. (2010). Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and metastasis in gastric cancer. APMIS 118, 196-202
10. Collado, M., and Serrano, M. (2010). Senescence in tumours: Evidence from mice and humans. Nat Rev Cancer 10, 51-57
11. Elmore, L.W., Rehder, C.W., Di, X., McChesney, P.A., Jackson- Cook, C.K., Gewirtz, D.A., and Holt, S.E. (2002). Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J Biol Chem 277, 35509-35515
12. Fan, T., Jiang, S., Chung, N., Alikhan, A., Ni, C., Lee, C.C., and Hornyak, T.J. (2011). EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Mol Cancer Res 9, 418-429
13. Gamboa-Dominguez, A., Seidl, S., Reyes-Gutierrez, E., Hermannstadter, C., Quintanilla-Martinez, L., Busch, R., Hofler, H., Fend, F., and Luber, B. (2007). Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer. J Clin Pathol 60, 756-761. (Pubitemid 47056903)
14. Gewirtz, D.A., Holt, S.E., and Elmore, L.W. (2008). Accelerated senescence: An emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 76, 947- 957
15. Goscinski, M.A., Larsen, S.G., Warloe, T., Stoldt, S., Nesland, J.M., Suo, Z.H., and Giercksky, K.E (2009). Adenocarcinomas on the rise - does it influence survival from oesophageal cancer? Scand J Surg 98, 214-220
16. Han, Z., Wei, W., Dunaway, S., Darnowski, J.W., Calabresi, P., Sedivy, J., Hendrickson, E.A., Balan, K.V., Pantazis, P., and Wyche, J.H. (2002). Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J Biol Chem 277, 17154-17160
17. Jackson, J.G., and Pereira-Smith, O.M. (2006). Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin- induced senescence of breast cancer cells. Mol Cell Biol 26, 2501-2510
18. Kuilman, T., Michaloglou, C., Mooi, W.J., and Peeper, D.S. (2010). The essence of senescence. Genes Dev 24, 2463-2479
19. Lukas, J., Parry, D., Aagaard, L., Mann, D.J., Bartkova, J., Strauss, M., Peters, G., and Bartek, J. (1995). Retinoblastomaprotein- dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375, 503-506
20. Matsukawa, Y., Semba, S., Kato, H., Ito, A., Yanagihara, K., and Yokozaki, H. (2006). Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer. Cancer Sci 97, 484-491
21. Mitomi, H., Fukui, N., Kishimoto, I., Tanabe, S., Kikuchi, S., Saito, T., Hayashi, T., and Yao, T. (2011). Role for p16(.INK4a) in progression of gastrointestinal stromal tumors of the stomach: Alteration of p16(.INK4a) network members. Hum Pathol 42, 1505-1513
22. Pal, B., Bouras, T., Shi, W., Vaillant, F., Sheridan, J.M., Fu, N., Breslin, K., Jiang, K., Ritchie, M.E., Young, M., Lindeman, G.J., Smyth, G.K., and Visvader, J.E. (2013). Global changes in the mammary epigenome are induced by hormonal cues and coordinated by Ezh2. Cell Rep 3, 411-426
23. Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108. (Pubitemid 40372904)
24. Schmitt, C.A., Fridman, J.S., Yang, M., Lee, S., Baranov, E., Hoffman, R.M., and Lowe, S.W. (2002). A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109, 335-346
25. Simon, J.A., and Lange, C.A. (2008). Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 647, 21-29
26. Tian, Y., Wan, H., and Tan, G. (2012). Cell cycle-related kinase in carcinogenesis. Oncol Lett 4, 601-606
27. Tzatsos, A., Paskaleva, P., Lymperi, S., Contino, G., Stoykova, S., Chen, Z., Wong, K.K., and Bardeesy, N. (2011). Lysinespecific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells. J Biol Chem 286, 33061- 33069
28. Wu, C.H., van Riggelen, J., Yetil, A., Fan, A.C., Bachireddy, P., and Felsher, D.W. (2007). Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation. Proc Natl Acad Sci U S A 104, 13028-13033
29. Yuasa, Y., Nagasaki, H., Akiyama, Y., Hashimoto, Y., Takizawa, T., Kojima, K., Kawano, T., Sugihara, K., Imai, K., and Nakachi, K. (2009). DNA methylation status is inversely correlated with green tea intake and physical activity in gastric cancer patients. Int J Cancer 124, 2677-2682
30. Zhu, W., Abbas, T., and Dutta, A. (2005). DNA replication and genomic instability. Adv Exp Med Biol 570, 249-279.